Year: 2007
Type: article
Abstract: Mycobacterium tuberculosis strains that are resistant to an increasing number of second-line drugs used to treat multidrug-resistant tuberculosis (MDR TB) are becoming a threat to public health worldwide. We surveyed the Network of Supranational Reference Laboratories for M. tuberculosis isolates that were resistant to second-line anti-TB drugs during 2000-2004. We defined extensively drug-resistant TB (XDR TB) as MDR TB with further resistance to > or = 3 of the 6 classes of second-line drugs. Of 23 eligible laboratories, 14 (61%) contributed data on 17,690 isolates, which reflected drug susceptibility results from 48 countries. Of 3,520 (19.9%) MDR TB isolates, 347 (9.9%) met criteria for XDR TB. Further investigation of population-based trends and expanded efforts to prevent drug resistance and effectively treat patients with MDR TB are crucial for protection of public health and control of TB.
Source: Emerging infectious diseases
Authors: N. Sarita Shah, Abigail Wright, Gill-Han Bai, Lucia Barrera, Fadila Boulahbal, Nuria Martín-Casabona, Francis Drobniewski, Chris Gilpin, Marta Havelková, Rosario Lepe, Richard Lumb, Beverly Metchock, Françoise Portaels, Maria Filomena Rodrigues, Sabine Rüsch-Gerdes, Armand Van Deun, Veronique Vincent, Kayla Laserson, Charles Wells, J. Peter Cegielski
Institutions: Centers for Disease Control and Prevention, World Health Organization, Korean Institute of Tuberculosis, Institut Pasteur d'Algérie, Vall d'Hebron Hospital Universitari, Health Protection Agency, Prince Charles Hospital, National Institute of Public Health, Instituto de Salud Pública de Chile, South Australia Pathology, Instituut voor Tropische Geneeskunde, Institut Pasteur
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2127258416
